---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-046527"
form_type: "8-K"
ticker: "TVGN"
cik: "0001860871"
company_name: "Tevogen Bio Holdings Inc."
filed_at: "2022-04-15T23:59:59+00:00"
generated_at: "2026-06-26T07:12:13.844571+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# CFO Philippe Kurzweil resigns; President Jeff Rogers appointed CFO and Secretary

## Summary
- Philippe J. Kurzweil resigned as CFO and Secretary, effective April 13, 2022.
- Jeff Rogers appointed CFO and Secretary, effective same day; he continues as President.
- Rogers has served as President since November 2021; biography incorporated by reference from Form 10-K.

## SEC filing metadata
- accession: 0001104659-22-046527
- form_type: 8-K
- ticker: TVGN
- cik: 0001860871
- company_name: Tevogen Bio Holdings Inc.
- filed_at: 2022-04-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860871/000110465922046527/0001104659-22-046527-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860871/000110465922046527/tm2212817d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-046527
- JSON: https://secwatch.observer/filing/0001104659-22-046527.json
- Plain text: https://secwatch.observer/filing/0001104659-22-046527.txt

## Key facts
- Executive change
  Philippe J. Kurzweil resigned as Chief Financial Officer and Secretary at Tevogen Bio Holdings Inc..
  - Action: resigned
  - Role: Chief Financial Officer and Secretary
  source text: On April 13, 2022, Philippe J. Kurzweil voluntarily resigned, effective immediately, as the Chief Financial Officer and Secretary of Semper Paratus Acquisition Corporation (the “Company”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1860871/000110465922046527/0001104659-22-046527-index.htm
- Executive change
  Jeff Rogers was appointed as Chief Financial Officer and Secretary at Tevogen Bio Holdings Inc..
  - Action: appointed
  - Role: Chief Financial Officer and Secretary
  source text: Effective as of April 13, 2022, the Board of Directors of the Company appointed Jeff Rogers to serve as the Company’s Chief Financial Officer and Secretary.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1860871/000110465922046527/0001104659-22-046527-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.